Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?

被引:160
作者
Meltzer, Herbert Y. [1 ]
Sumiyoshi, Tomiki [2 ]
机构
[1] Vanderbilt Univ, Sch Med, Vanderbilt Psychiat Hosp, Dept Psychiat, Nashville, TN 37212 USA
[2] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 9300194, Japan
关键词
Serotonin; 5-HT1A; Cognition; Dopamine; Schizophrenia;
D O I
10.1016/j.bbr.2008.05.016
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Cognitive impairment is a key feature of schizophrenia and may be the most important determinant of outcome in schizophrenia. This impairment is diffuse and may reflect abnormalities in frontal cortex, hippocampus and other brain regions. While deficits in glutamatergic, GABAergic, dopaminergic and cholinergic impairment have received the most attention as the basis of this impairment, there are many reasons for considering the role of serotonin (5-HT) in contributing to these deficits. This may be via its influence on dopaminergic, cholinergic, glutamatergic and GABAergic function, as well as various growth factors that have been implicated in schizophrenia. Of the 14 known serotonin receptors, the 5-HT1A receptor is a key candidate for mediating at least some of the influence 5-HT has on cognition. 5-HT1A receptors are upregulated in postmortem specimens from patients with schizophrenia, suggesting a deficit in 5-HT1A function in this disorder. Atypical but not typical antipsychotic drugs stimulate the efflux of dopamine from cortex by a 5-HT1A-dependent mechanism. A series of studies from this laboratory involving the 5-HT1A partial agonists tandospirone and buspirone have reported a modest ability of these agents to improve some domains of cognition in patients receiving typical or atypical antipsychotic drugs. Preclinical studies have been mixed in regard to the ability of 5-HT1A partial agonists to improve cognition in various paradigms; some studies report that 5-HT1A antagonists are effective to improve cognition. Aripiprazole, clozapine, olanzapine, perospirone, quetiapine risperidone, and ziprasidone are examples of atypical antipsychotic drugs which are either direct or indirect 5-HT1A agonists which have been shown to improve cognitive function in patients with schizophrenia. Further study is needed to determine the role of the 5-HT1A receptor to improve cognitive function in schizophrenia. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 65 条
  • [1] Perospirone in the treatment of schizophrenia: Effect on verbal memory organization
    Araki, T
    Yamasue, H
    Sumiyoshi, T
    Kuwabara, H
    Suga, M
    Iwanami, A
    Kato, N
    Kasai, K
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (02) : 204 - 208
  • [2] Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714:: a microdialysis study in the rat
    Assie, M-B
    Lomenech, H.
    Ravailhe, V.
    Faucillon, V.
    Newman-Tancredi, A.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (02) : 170 - 178
  • [3] Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics:: Frontocortical dopamine and hippocampal serotonin release in rat brain
    Assié, MB
    Ravailhe, V
    Faucillon, V
    Newman-Tancredi, A
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (01) : 265 - 272
  • [4] The 5-HT1A receptor in schizophrenia:: a promising target for novel atypical neuroleptics?
    Bantick, RA
    Deakin, JFW
    Grasby, PM
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (01) : 37 - 46
  • [5] SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities:: improvement of social interaction deficits induced by phencyclidine in rats
    Boulay, D
    Depoortère, R
    Louis, C
    Perrault, G
    Griebel, G
    Soubrié, P
    [J]. NEUROPHARMACOLOGY, 2004, 46 (08) : 1121 - 1129
  • [6] EFFECTS OF BUSPIRONE IN 7 SCHIZOPHRENIC SUBJECTS
    BRODY, D
    ADLER, LA
    KIM, T
    ANGRIST, B
    ROTROSEN, J
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1990, 10 (01) : 68 - 69
  • [7] Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance task
    Bubenikova-Valesova, Vera
    Stuchlik, Ales
    Svoboda, Jan
    Bures, Jan
    Vales, Karel
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (03) : 1061 - 1066
  • [8] 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia
    Burnet, PWJ
    Eastwood, SL
    Harrison, PJ
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 15 (05) : 442 - 455
  • [9] [H-3]WAY-100635 for 5-HT1A receptor autoradiography in human brain: A comparison with [H-3]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia
    Burnet, PWJ
    Eastwood, SL
    Harrison, PJ
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1997, 30 (06) : 565 - 574
  • [10] Chamberlain SR, 2007, J PSYCHOPHARMACOL, V21, P210, DOI 10.1177/0269881107068066